Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform ...

Copyright 2025 The Associated Press. All Rights Reserved. Afghan refugees hold placards during a meeting to discuss their situation after President Donald Trump ...

Hours after initially being named, fast bowler Gerald Coetzee has been ruled out of Proteas white-ball coach Rob Walter's provisional squad for the Tri-Nation ODI series against hosts Pakistan and New ...

The geopolitical landscape of South Asia is currently abuzz with discussions on the renewed warmth in Pakistan–Bangladesh relations. In India—and consequently, much of the world—the ...

L’Oreal OR-1.27%decrease; red down pointing triangle will sell part of its stake in Sanofi SAN-0.21%decrease; red down pointing triangle back to the French pharmaceutical company for 3 billion ...

Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company takes its lead candidate through a prostate cancer trial. The Pb-212 ...

Paris, February 3, 2025. Sanofi today announces the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi’s share buyback program ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

ISLAMABAD: Fertility rate has declined in Pakistan from six live births per woman in 1994 to 3.6 per woman in 2024, says World Fertility Report 2024 of the UN. The advance unedited report ...

Sanofi is planning a $5.12bn share buyback programme in 2025. Image credit: Shutterstock / JHVEPhoto. Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L’Oréal, the first of ...

Analyst Graham Parry of Bank of America Securities reiterated a Buy rating on Sanofi (SNYNF – Research Report), boosting the price target to €123.00. Graham Parry has given his Buy rating due ...